Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging.
Front Oncol
; 12: 800400, 2022.
Article
en En
| MEDLINE
| ID: mdl-36119501
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Front Oncol
Año:
2022
Tipo del documento:
Article